About JHCO Tokyo Yamate Medical Center
JCHO東京山手メディカルセンターは、東京都新宿区百人町にある医療機関。独立行政法人地域医療機能推進機構が運営する病院である。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
6
Pfizer
4
Takeda
3
Arena Pharmaceuticals
2
Boehringer Ingelheim
2
Galapagos NV
2
Janssen Research & Development, LLC
2
Bayer
1
Gilead Sciences
1
Janssen Pharmaceutical K.K.
1
Janssen-Cilag Ltd.
1
Clinical Trials at JHCO Tokyo Yamate Medical Center
During the past decade, JHCO Tokyo Yamate Medical Center conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 8 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 7 clinical trials were completed. i.e. 77.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
2010-09-01
2016-06-01
Terminated
2,867
Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)
2016-01-04
2019-08-06
Completed
644
A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease
2016-04-15
2023-05-06
Active, not recruiting
746
A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease
2016-12-14
2021-02-05
Completed
191
Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
2016-11-14
2020-03-31
Completed
1,351
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
2017-02-23
2026-09-01
Active, not recruiting
1,173
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
2016-10-31
2022-11-11
Completed
1,374
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
2018-04-13
2030-06-30
Active, not recruiting
1,409
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "JHCO Tokyo Yamate Medical Center" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Pfizer" with 4 trials
sponsored, "Takeda" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Boehringer Ingelheim"
with 2 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "JHCO Tokyo Yamate Medical Center"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 3 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at JHCO Tokyo Yamate Medical Center
According to Clinical.Site data, the most researched conditions in "JHCO Tokyo Yamate Medical Center" are
"Ulcerative Colitis" (12 trials), "Crohn's Disease" (9 trials), "Colitis, Ulcerative" (3 trials), "Atrial Fibrillation" (1 trials) and "Fistulizing Crohns Disease" (1 trials). Many other conditions were trialed in "JHCO Tokyo Yamate Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at JHCO Tokyo Yamate Medical Center
Most popular intervention types in "JHCO Tokyo Yamate Medical Center" are "Drug" (25 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Etrasimod" (5 trials), "Mirikizumab" (5 trials), "Filgotinib" (3 trials) and "Guselkumab" (3 trials). Other intervention names were less common.
Clinical Trials Genders at JHCO Tokyo Yamate Medical Center
The vast majority of trials in "JHCO Tokyo Yamate Medical Center" are
25 trials for "All" genders.
Clinical Trials Status at JHCO Tokyo Yamate Medical Center
Currently, there are NaN active trials in "JHCO Tokyo Yamate Medical Center".
undefined are not yet recruiting,
9 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in JHCO Tokyo Yamate Medical Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in JHCO Tokyo Yamate Medical Center, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 21 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".